The New Era of Healthcare Begins in Childhood
Healthcare has historically been built around adult medicine, with pediatric care too often relying on therapies developed for adults.
The greatest healthcare companies of the next decade will intervene earlier by fundamentally altering disease before lifelong consequences emerge.
Today, scientific and technological advances are making that possible in ways that did not exist a decade ago.
Science has moved upstream.
Venture capital has not.
Pediatric and maternal health represent a $400 B market serving nearly 25% of the U.S. population, yet historically attract less than 1% of venture capital. The disconnect is evident across the pediatric care continuum.
1 in 3
children live with a chronic condition
1 in 12
mothers lack access to care
1 in 2
prescriptions are off label
Pediatrics is fundamentally different from adult medicine.
Pediatric biology, clinical development, regulatory pathways, and commercialization require specialized expertise, creating barriers that have historically limited investment despite the market's scale.
Earlier intervention improves outcomes.
We help build category leaders in pediatrics.